Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Arcutis Biotherapeutics (ARQT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO – Research Report) and ...
The Pharma Letter2d
DMD market set for strong growth in coming years
The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across ...
cweb2d
Moderna, Inc. (NASDAQ:MRNA) Faces Challenges and Opportunities in Biotech Sector
Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...
Le Lézard2d
Pro-Grade Inventory from Global Leader in Audiovisual and Entertainment Technology Goes to Auction on February 25
A Tiger Group online auction on February 25 features excess AV gear from Solotech. "Tiger Group is extremely pleased to have been selected by Solotech as the asset-disposition provider for its ...
Le Lézard2d
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
Delcath Systems, Inc. ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update to the ...
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it ...
Regenerative Medicine Market Projected To Witness Substantial Growth, 2025-2032 Novartis AG (Switzerland), Biogen
Regenerative Medicine Market Growth BURLINGAME, CA, UNITED STATES, February 14, 2025 /EINPresswire / --The global Regenerative Medicin ...
State of Alaska Department of Revenue Sells 145 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
State of Alaska Department of Revenue reduced its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.3% ...
Deutsche Bank Aktiengesellschaft Initiates Coverage on Sarepta Therapeutics (NASDAQ:SRPT)
Equities research analysts at Deutsche Bank Aktiengesellschaft assumed coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) in a research report issued on Tuesday, MarketBeat ...